Skip to content
HowShorted

Aptevo Therapeutics Inc. short interest in 2026

In 2026, Aptevo Therapeutics Inc.'s disclosed short interest ran from 11.26% of shares outstanding on 31 Mar 2026 to 10.43% on 15 Sep 2026, a change of -0.83 percentage points. The year's high was 11.26% on 31 Mar 2026 and its low 4.54% on 14 Aug 2026, averaging 7.81% across 12 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 5.09 days on 30 Apr 2026. Full history: Aptevo Therapeutics Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2026

Aggregate net short position time series for Aptevo Therapeutics Inc. in 2026

2026 in figures

Start of year
11.26% (31 Mar 2026)
End of year
10.43% (15 Sep 2026)
Change
-0.83 pp
High
11.26% (31 Mar 2026)
Low
4.54% (14 Aug 2026)
Average
7.81%
Highest days to cover
5.09 (30 Apr 2026)
SEC filings marked
6

Every report in 2026

Aptevo Therapeutics Inc. short interest in 2026
SettlementShort interestDays to coverFilings since previous
31 Mar 202611.26%2.4810-K filed, results (8-K)
15 Apr 20268.82%3.80
30 Apr 20267.80%5.09
15 May 20267.05%1.4910-Q filed, results (8-K)
29 May 20266.43%2.68
15 Jun 20266.43%2.17
30 Jun 20266.37%3.41
15 Jul 202611.01%1.00
31 Jul 20267.03%4.53
14 Aug 20264.54%2.4210-Q filed, results (8-K)
31 Aug 20266.56%1.93
15 Sep 202610.43%1.00

See also: Aptevo Therapeutics Inc.'s full history · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.